Trial Profile
To evaluate the effect of Fingolimod treatment on natural killer cells on patients with relapasing remitting Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Nov 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 23 Nov 2016 New trial record